HLB Life Science Co., Ltd. (KOSDAQ:067630)
South Korea
· Delayed Price · Currency is KRW 6,620.00
+330.00 (5.25%)
Apr 1, 2025, 3:30 PM KST
HLB Life Science Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 102,240 | 97,990 | 99,591 | 53,494 | 91,797 | Upgrade
|
| Other Revenue | - | - | 0 | 0 | -0 | Upgrade
|
| Revenue | 102,240 | 97,990 | 99,591 | 53,494 | 91,797 | Upgrade
|
| Revenue Growth (YoY) | 4.34% | -1.61% | 86.17% | -41.73% | -19.49% | Upgrade
|
| Cost of Revenue | 104,809 | 98,915 | 102,813 | 59,155 | 89,630 | Upgrade
|
| Gross Profit | -2,569 | -925.04 | -3,222 | -5,661 | 2,167 | Upgrade
|
| Selling, General & Admin | 14,337 | 15,226 | 10,839 | 8,247 | 7,959 | Upgrade
|
| Research & Development | 5,177 | 5,454 | 4,349 | 3,846 | 1,431 | Upgrade
|
| Other Operating Expenses | 394.66 | 279 | 192.67 | 113.46 | 211.74 | Upgrade
|
| Operating Expenses | 18,470 | 24,568 | 16,728 | 12,668 | 10,184 | Upgrade
|
| Operating Income | -21,038 | -25,493 | -19,950 | -18,329 | -8,018 | Upgrade
|
| Interest Expense | -16,819 | -21,650 | -9,870 | -1,256 | -2,109 | Upgrade
|
| Interest & Investment Income | 1,880 | 1,288 | 1,203 | 512.76 | 1,715 | Upgrade
|
| Earnings From Equity Investments | 1,354 | -2,537 | 2,602 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 121.23 | -93.22 | 33.77 | -4.05 | 111.25 | Upgrade
|
| Other Non Operating Income (Expenses) | 119.02 | 469.76 | -2,664 | -60.63 | 1,548 | Upgrade
|
| EBT Excluding Unusual Items | -34,383 | -48,015 | -28,646 | -19,137 | -6,752 | Upgrade
|
| Gain (Loss) on Sale of Investments | 61,670 | 81,336 | -20,548 | -21,296 | -27,533 | Upgrade
|
| Gain (Loss) on Sale of Assets | 23.84 | -304.96 | 3,157 | 594.55 | 313.04 | Upgrade
|
| Asset Writedown | -24,162 | -37,553 | -14,802 | -13,786 | -22,519 | Upgrade
|
| Other Unusual Items | - | -1,966 | - | - | - | Upgrade
|
| Pretax Income | 3,149 | -6,503 | -60,839 | -53,624 | -56,490 | Upgrade
|
| Income Tax Expense | -3,058 | -590.06 | -6,479 | -4,333 | -654.25 | Upgrade
|
| Earnings From Continuing Operations | 6,207 | -5,913 | -54,360 | -49,292 | -55,836 | Upgrade
|
| Net Income to Company | 6,207 | -5,913 | -54,360 | -49,292 | -55,836 | Upgrade
|
| Minority Interest in Earnings | -68.89 | -70.35 | 82.24 | 139.89 | 38.95 | Upgrade
|
| Net Income | 6,138 | -5,983 | -54,277 | -49,152 | -55,797 | Upgrade
|
| Net Income to Common | 6,138 | -5,983 | -54,277 | -49,152 | -55,797 | Upgrade
|
| Shares Outstanding (Basic) | 114 | 103 | 101 | 99 | 99 | Upgrade
|
| Shares Outstanding (Diluted) | 114 | 103 | 101 | 99 | 99 | Upgrade
|
| Shares Change (YoY) | 10.18% | 2.17% | 1.64% | 0.34% | 6.39% | Upgrade
|
| EPS (Basic) | 54.00 | -58.00 | -537.56 | -494.76 | -563.59 | Upgrade
|
| EPS (Diluted) | 54.00 | -58.00 | -537.56 | -494.76 | -563.85 | Upgrade
|
| Free Cash Flow | -59,301 | -30,634 | -40,420 | -16,505 | -6,400 | Upgrade
|
| Free Cash Flow Per Share | -521.72 | -296.95 | -400.32 | -166.14 | -64.64 | Upgrade
|
| Gross Margin | -2.51% | -0.94% | -3.23% | -10.58% | 2.36% | Upgrade
|
| Operating Margin | -20.58% | -26.02% | -20.03% | -34.26% | -8.73% | Upgrade
|
| Profit Margin | 6.00% | -6.11% | -54.50% | -91.88% | -60.78% | Upgrade
|
| Free Cash Flow Margin | -58.00% | -31.26% | -40.59% | -30.85% | -6.97% | Upgrade
|
| EBITDA | -15,138 | -17,797 | -14,727 | -15,845 | -5,763 | Upgrade
|
| EBITDA Margin | -14.81% | -18.16% | -14.79% | -29.62% | -6.28% | Upgrade
|
| D&A For EBITDA | 5,901 | 7,696 | 5,223 | 2,484 | 2,255 | Upgrade
|
| EBIT | -21,038 | -25,493 | -19,950 | -18,329 | -8,018 | Upgrade
|
| EBIT Margin | -20.58% | -26.02% | -20.03% | -34.26% | -8.73% | Upgrade
|
| Advertising Expenses | 96.93 | 157.86 | 69.13 | 34.92 | 41.38 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.